Register entry
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 39
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3939 active NDC listings: 39 bulk ingredient. By marketing category: BULK INGREDIENT 39.
| Dosage form | NDCs |
|---|---|
| powder | 35 |
| crystal | 2 |
| injection, solution | 1 |
| oil | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| chunghwa chemical synthesis & biotech. ltd | 29 |
| chunghwa chemical synthesis & biotech co., ltd. | 10 |
Catalogue
Marketed products
39| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ABALOPARATIDE | powder | 52076-6229BULK INGREDIENT |
| - | AHU377 SODIUM | powder | 52076-6260BULK INGREDIENT |
| - | BARICITINIB | crystal | 52076-6225BULK INGREDIENT |
| - | Carfilzomib | powder | 52076-6251BULK INGREDIENT |
| - | Dalbavancin hydrochloride | powder | 52076-6279BULK INGREDIENT |
| - | ELTROMBOPAG OLAMINE | powder | 52076-6274BULK INGREDIENT |
| - | ETELCALCETIDE | powder | 52076-6227BULK INGREDIENT |
| - | ETELCALCETIDE HYDROCHLORIDE | powder | 52076-6228BULK INGREDIENT |
| - | ETHYL ICOSAPENTATE | oil | 52076-6204BULK INGREDIENT |
| - | EVEROLIMUS | powder | 52076-6234BULK INGREDIENT |
| - | Everolimus | powder | 52076-6247BULK INGREDIENT |
| - | Everolimus | powder | 52076-6253BULK INGREDIENT |
| - | IXAZOMIB CITRATE | powder | 52076-6224BULK INGREDIENT |
| - | LCZ696 | powder | 52076-6258BULK INGREDIENT |
| - | LIXIANA | powder | 52076-6256BULK INGREDIENT |
| - | METAXALONE | powder | 52076-6231BULK INGREDIENT |
| - | METHOCARBAMOL | powder | 52076-6206BULK INGREDIENT |
| - | MIDOSTAURIN | powder | 52076-6262BULK INGREDIENT |
| - | MYCOPHENOLATE MOFETIL | powder | 52076-6220BULK INGREDIENT |
| - | MYCOPHENOLATE MOFETIL HYDROCHLORIDE ANHYDROUS | powder | 52076-6235BULK INGREDIENT |
| - | MYCOPHENOLATE SODIUM | powder | 52076-6236BULK INGREDIENT |
| - | Mycophenolic Acid | powder | 52076-6215BULK INGREDIENT |
| - | Ozanimod | powder | 52076-6281BULK INGREDIENT |
| - | PALBOCICLIB | crystal | 52076-6263BULK INGREDIENT |
| - | PLECANATIDE | powder | 52076-6226BULK INGREDIENT |
| - | RIBOCICLIB SUCCINATE | powder | 52076-6203BULK INGREDIENT |
| - | RUXOLITINIB PHOSPHATE | powder | 52076-6276BULK INGREDIENT |
| - | Ruxolitinib free base | powder | 52076-6277BULK INGREDIENT |
| - | Selumetinib Sulfate | powder | 52076-6278BULK INGREDIENT |
| - | Semaglutide | powder | 52076-6282BULK INGREDIENT |
| - | TRILACICLIB DIHYDROCHLORIDE | powder | 52076-6275BULK INGREDIENT |
| - | Tacrolimus | powder | 52076-6222BULK INGREDIENT |
| - | Tenapanor Hydrochloride | powder | 52076-6284BULK INGREDIENT |
| - | Trilaciclib dihydrochloride | powder | 52076-6280BULK INGREDIENT |
| - | caspofungin acetate | powder | 52076-6230BULK INGREDIENT |
| - | lanreotide acetate | powder | 52076-6264BULK INGREDIENT |
| - | lcz696 | injection, solution | 52076-6259BULK INGREDIENT |
| - | rapamycin | powder | 52076-6216BULK INGREDIENT |
| - | ribociclib free base | powder | 52076-6261BULK INGREDIENT |
Compare
Other companies listing everolimus
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Par Health USA, LLC5 sites · 211 NDC
- NATCO PHARMA LIMITED5 sites · 108 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- BrightGene Bio-Medical Technology Co., Ltd.4 sites · 19 NDC
- Concord Biotech Limited3 sites · 42 NDC
- ScinoPharm Taiwan, Ltd.1 site · 87 NDC
Enquiry
Common questions
- Is Chunghwa Chemical Synthesis & Biotech Co., Ltd. FDA approved?
- Chunghwa Chemical Synthesis & Biotech Co., Ltd. holds no registered establishment of its own; 39 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Chunghwa Chemical Synthesis & Biotech Co., Ltd. make?
- 39 products are listed under Chunghwa Chemical Synthesis & Biotech Co., Ltd. in the openFDA NDC Directory, most often as powder; crystal; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.